Pre-Emptive or Reactive Treatment of Cutaneous Rash Induced by Epidermal Growth Factor Receptor Inhibitors: Does It Matter?

J Clin Oncol. 2016 Mar 10;34(8):774-6. doi: 10.1200/JCO.2015.64.7529. Epub 2015 Dec 28.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • ErbB Receptors*
  • Exanthema / chemically induced*
  • Humans
  • Protein Kinase Inhibitors / therapeutic use
  • Quinazolines / therapeutic use

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Quinazolines
  • ErbB Receptors